According to a new article, the leading cause of death by bacterial infection, Staphylococcus aureus, may soon have vaccine candidates in clinical trials.
Over the last quarter of a century, approximately 14 investigational S aureus vaccine candidates have failed in phase 2 or 3 clinical trials. No matter how promising the strategy or how well the candidate worked in preclinical studies, none has successfully protected humans from S aureus.
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
